CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 30 enrolled
Drug / intervention
Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01541254
NCT01541254Phase 3Completed

A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms

Microvention-Terumo, Inc.·interventional·Posted Feb 29, 2012·Updated Jul 1, 2025

In Brief

A Phase 3 clinical trial evaluating Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.) for Intracranial Aneurysms. Completed, enrolled 30 participants across 6 sites.

Detailed Summary

The purpose of this study is to evaluate the safety and probable benefit of the Low-profile Visualized Intraluminal Support (LVIS™ and LVIS™ Jr.)devices from MicroVention, Inc. when used to facilitate endovascular coiling of unruptured wide-neck intracranial aneurysms with bare platinum embolization coils.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 29, 2012
Enrollment StartMar 1, 2012
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.3 years ago

Interventions

Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.)device

Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.)